CoChat
Sign Up
Cited by 1,989Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentUterine Myomas and Treatments

ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma

Open access
Concin, Nicole, Matias-Guiu, Xavier, Vergote, Ignace, Cibula, David, Mirza, Mansoor Raza, Marnitz, Simone, Ledermann, Jonathan, Bosse, Tjalling +20 more·2021·International Journal of Gynecological Cancer
DOI 10.1136/ijgc-2020-002230
Open this paper in CoChat — free accountOpen PDF

Abstract

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ijgc-2020-002230

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 426

  1. Joint statement 1999-2007: results of the EUROCARE-5 study. Eur J Cancer 2015;51:2191-205. · DOI
  2. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016;26:2-30. · DOI
  3. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Radiother Oncol 2015;117:559-81. · DOI
  4. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 2016;27:16-41. · DOI
  5. Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi33-8. · DOI
  6. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001;33:139-44. · DOI
  7. Ryan NAJ, Glaire MA, Blake D, et al. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med 2019;21:2167-80. · DOI
  8. Cho KR, Cooper K, Croce S, et al. International Society of Gynecological Pathologists (ISGyP) endometrial cancer project: guidelines from the special techniques and ancillary studies group. Int J Gynecol Pathol 2019;38 Suppl 1:S114-22. · DOI
  9. Crosbie EJ, Ryan NAJ, Arends MJ, et al. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 2019;21:2390-400. · DOI
  10. Mills AM, Liou S, Ford JM, et al. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 2014;38:1501-9. · DOI
  11. Mojtahed A, Schrijver I, Ford JM, et al. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol 2011;24:1004-14. · DOI
  12. Shia J, Tang LH, Vakiani E, et al. Immunohistochemistry as first- line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 2009;33:1639-45. · DOI
  13. Møller P, Seppälä T, Bernstein I, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 2017;66:464-72. · DOI
  14. Ryan NAJ, Morris J, Green K, et al. Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol 2017;3:1702-6. · DOI
  15. Lachiewicz MP, Kravochuck SE, O'Malley MM, et al. Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome. Gynecol Oncol 2014;132:434-7. · DOI
  16. Kandoth C, Schultz N, et al, Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67-73. · DOI · Paper page
  17. Piulats JM, Guerra E, Gil-Martín M, et al. Molecular approaches for classifying endometrial carcinoma. Gynecol Oncol 2017;145:200-7. · DOI
  18. Talhouk A, McConechy MK, Leung S, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer 2015;113:299-310. · DOI
  19. Talhouk A, McConechy MK, Leung S, et al. Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer. Cancer 2017;123:802-13. · DOI
  20. Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res 2016;22:4215-24. · DOI
  21. León-Castillo A, de Boer SM, Powell ME, et al. Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 2020;38:3388-97. · DOI
  22. León-Castillo A, Gilvazquez E, Nout R, et al. Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas. J Pathol 2020;250:312-22. · DOI
  23. Vermij L, Smit V, Nout R, et al. Incorporation of molecular characteristics into endometrial cancer management. Histopathology 2020;76:52-63. · DOI
  24. Church DN, Stelloo E, Nout RA, et al. Prognostic significance of POLE proofreading mutations in endometrial cancer. J Natl Cancer Inst 2015;107. · DOI
  25. León-Castillo A, Britton H, McConechy MK, et al. Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol 2020;250:323-35. · DOI
  26. McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018;244:538-49. · DOI
  27. Köbel M, Nelson GS. Letter in response to: McAlpine J, Leon- Castillo a, Bosse T. the rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018; 244: 538-549. J Pathol 2018;245:249-50. · DOI
  28. Kommoss FKF, Karnezis AN, Kommoss F, et al. L1Cam further stratifies endometrial carcinoma patients with no specific molecular risk profile. Br J Cancer 2018;119:480-6. · DOI
  29. van der Putten LJM, Visser NCM, van de Vijver K, et al. L1CAM expression in endometrial carcinomas: an ENITEC collaboration study. Br J Cancer 2016;115:716-24. · DOI
  30. Van Gool IC, Stelloo E, Nout RA, et al. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer. Mod Pathol 2016;29:174-81. · DOI
  31. Bosse T, Nout RA, Stelloo E, et al. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results. Eur J Cancer 2014;50:2602-10. · DOI
  32. Ali A, Black D, Soslow RA. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 2007;26:115-23. · DOI
  33. Luomaranta A, Leminen A, Loukovaara M. Magnetic resonance imaging in the assessment of high-risk features of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 2015;25:837-42. · DOI
  34. Andreano A, Rechichi G, Rebora P, et al. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 2014;24:1327-38. · DOI
  35. Das SK, Niu XK, Wang JL, et al. Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis. Cancer Imaging 2014;14. · DOI
  36. Deng L, Wang Q-P, Chen X, et al. The combination of diffusion-and T2-weighted imaging in predicting deep myometrial invasion of endometrial cancer. J Comput Assist Tomogr 2015;39:661-73. · DOI
  37. Alcázar JL, Gastón B, Navarro B, et al. Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis. J Gynecol Oncol 2017;28:e86. · DOI
  38. Tanaka T, Terai Y, Fujiwara S, et al. Preoperative diffusion-weighted magnetic resonance imaging and intraoperative frozen sections for predicting the tumor grade in endometrioid endometrial cancer. Oncotarget 2018;9:36575-84. · DOI
  39. Sánchez MF, Causa Andrieu PI, Latapie C, et al. Diagnostic yield of magnetic resonance imaging and intraoperative frozen section in the determination of deep myometrial invasion in endometrial cancer. Radiología 2019;61:315-23. · DOI
  40. Fasmer KE, Bjørnerud A, Ytre-Hauge S, et al. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion- weighted imaging predict aggressive disease in endometrial cancer. Acta Radiol 2018;59:1010-7. · DOI
  41. Taufiq M, Masroor I, Hussain Z. Diagnostic accuracy of diffusion weighted magnetic resonance imaging in the detection of myometrial invasion in endometrial carcinoma. J Coll Physicians Surg Pak 2016;26:13-17.
  42. Christensen JW, Dueholm M, Hansen ES, et al. Assessment of myometrial invasion in endometrial cancer using three-dimensional ultrasound and magnetic resonance imaging. Acta Obstet Gynecol Scand 2016;95:55-64. · DOI
  43. Arnaiz J, Muñoz A-B, Verna V, et al. Magnetic resonance imaging for the pre-surgical assessment of endometrial cancer: results in a routine clinical setting, outside dedicated trials; a cross-sectional study. Anticancer Res 2016;36:1891-4.
  44. Shrivastava S, Barmon D, Kataki AC, et al. Magnetic resonance imaging in pre-operative staging of endometrial cancer. Indian J Cancer 2016;53:181-5. · DOI
  45. Body N, Lavoué V, De Kerdaniel O, et al. Are preoperative histology and MRI useful for classification of endometrial cancer risk? BMC Cancer 2016;16:498. · DOI
  46. Rodríguez-Trujillo A, Martínez-Serrano MJ, Martínez-Román S, et al. Preoperative assessment of myometrial invasion in endometrial cancer by 3D ultrasound and diffusion-weighted magnetic copyright. on December 18, 2020 at KU Leuven Libraries. Protected by http://ijgc.bmj.com/ Int J Gynecol Cancer: first published as 10.1136/ijgc-2020-002230 on 18 December 2020. Downloaded from Concin N, et al. Int J Gynecol Cancer 2020;0:12-39. doi:10.1136/ijgc-2020-002230 Joint statement resonance imaging: a comparative study. Int J Gynecol Cancer 2016;26:1105-10. · DOI
  47. Horváth K, Pete I, Vereczkey I, et al. Evaluation of the accuracy of preoperative MRI in measuring myometrial infiltration in endometrial carcinoma. Pathol Oncol Res 2014;20:327-33. · DOI
  48. Nougaret S, Reinhold C, Alsharif SS, et al. Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology 2015;276:797-808. · DOI
  49. Ippolito D, Cadonici A, Bonaffini PA, et al. Semiquantitative perfusion combined with diffusion-weighted MR imaging in pre- operative evaluation of endometrial carcinoma: results in a group of 57 patients. Magn Reson Imaging 2014;32:464-72. · DOI
  50. Tanaka T, Terai Y, Ono YJ, et al. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer. Int J Gynecol Cancer 2015;25:879-83. · DOI
  51. Bonatti M, Stuefer J, Oberhofer N, et al. MRI for local staging of endometrial carcinoma: is endovenous contrast medium administration still needed? Eur J Radiol 2015;84:208-14. · DOI
  52. Karataşlı V, Çakır İ, Şahin H, et al. Can preoperative magnetic resonance imaging replace intraoperative frozen sectioning in the evaluation of myometrial invasion for early-stage endometrial carcinoma? Ginekol Pol 2019;90:128-33. · DOI
  53. Fujii S, Kido A, Baba T, et al. Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. Eur J Radiol 2015;84:581-9. · DOI
  54. Yang T, Tian S, Li Y, et al. Magnetic resonance imaging (MRI) and three-dimensional transvaginal ultrasonography scanning for preoperative assessment of high risk in women with endometrial cancer. Med Sci Monit 2019;25:2024-31. · DOI
  55. Ahmed M, Al-Khafaji JF, Class CA, et al. Can MRI help assess aggressiveness of endometrial cancer? Clin Radiol 2018;73:833. e11-833.e18. · DOI
  56. Sahin H, Sarioglu FC, Bagci M, et al. Preoperative magnetic resonance volumetry in predicting myometrial invasion, lymphovascular space invasion, and tumor grade: is it valuable in International Federation of Gynecology and Obstetrics stage I endometrial cancer? Int J Gynecol Cancer 2018;28:666-74. · DOI
  57. Yan B, Zhao T, Liang X, et al. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer? Acta Radiol 2018;59:363-70. · DOI
  58. Zhang L, Liu A, Zhang T, et al. Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study. Acta Radiol 2015;56:1273-80. · DOI
  59. Bonatti M, Pedrinolla B, Cybulski AJ, et al. Prediction of histological grade of endometrial cancer by means of MRI. Eur J Radiol 2018;103:44-50. · DOI
  60. Tsikouras P, Koukouli Z, Bothou A, et al. Preoperative assessment in endometrial cancer: is triage for lymphadenectomy possible? J Buon 2017;22:34-43.
  61. Zamani N, Modares Gilani M, Zamani F, et al. Utility of pelvic MRI and tumor markers HE4 and CA125 to predict depth of myometrial invasion and cervical involvement in endometrial cancer. J Family Reprod Health 2015;9:177-83.
  62. Bourgioti C, Chatoupis K, Tzavara C, et al. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer. Abdom Radiol 2016;41:2484-95. · DOI
  63. Ytre-Hauge S, Dybvik JA, Lundervold A, et al. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. J Magn Reson Imaging 2018;48:1637-47. · DOI
  64. Thieme SF, Collettini F, Sehouli J, et al. Preoperative evaluation of myometrial invasion in endometrial carcinoma: prospective intra- individual comparison of magnetic resonance volumetry, diffusion- weighted and dynamic contrast-enhanced magnetic resonance imaging. Anticancer Res 2018;38:4813-7. · DOI
  65. Deng L, Wang Q-P, Yan R, et al. Combined subjective and quantitative analysis of magnetic resonance images could improve the diagnostic performance of deep myometrial invasion in endometrial cancer. Clin Imaging 2017;43:69-73. · DOI
  66. Gallego JC, Porta A, Pardo MC, et al. Evaluation of myometrial invasion in endometrial cancer: comparison of diffusion-weighted magnetic resonance and intraoperative frozen sections. Abdom Imaging 2014;39:1021-6. · DOI
  67. Brocker KA, Radtke JP, Hallscheidt P, et al. Comparison of the determination of the local tumor extent of primary endometrial cancer using clinical examination and 3 tesla magnetic resonance imaging compared to histopathology. Arch Gynecol Obstet 2019;299:1391-8. · DOI
  68. Goel G, Rajanbabu A, Sandhya CJ, et al. A prospective observational study evaluating the accuracy of MRI in predicting the extent of disease in endometrial cancer. Indian J Surg Oncol 2019;10:220-4. · DOI
  69. Cignini P, Vitale SG, Laganà AS, et al. Preoperative work- up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 2017;69:75-82. · DOI
  70. Soneji ND, Bharwani N, Ferri A, et al. Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results? Eur Radiol 2018;28:4725-34. · DOI
  71. Green RW, Valentin L, Alcazar JL, et al. Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three- dimensional volume contrast imaging: intermethod agreement, interrater reliability and diagnostic accuracy. Gynecol Oncol 2018;150:438-45. · DOI
  72. Takeuchi M, Matsuzaki K, Harada M. Evaluating myometrial invasion in endometrial cancer: comparison of reduced field-of- view diffusion-weighted imaging and dynamic contrast-enhanced MR imaging. MRMS 2018;17:28-34. · DOI
  73. Ota T, Hori M, Onishi H, et al. Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study. Eur Radiol 2017;27:5225-35. · DOI
  74. Koplay M, Dogan NU, Erdogan H, et al. Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma. J Med Imaging Radiat Oncol 2014;58:538-46. · DOI
  75. Woo S, Kim SY, Cho JY, et al. Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second- opinion interpretations by radiologists subspecialized in gynaecologic oncology. Eur Radiol 2017;27:1877-82. · DOI
  76. Alves I, Cunha TM. Clinical importance of second-opinion interpretations by radiologists specializing in gynecologic oncology at a tertiary cancer center: magnetic resonance imaging for endometrial cancer staging. Radiol Bras 2018;51:26-31. · DOI
  77. Masroor I, Rashid S, Afzal S, et al. Diagnostic accuracy of pelvic MRI for determination of the cervical involvement in endometrial cancer. J Coll Physicians Surg Pak 2018;27:262-5. · DOI
  78. Teng F, Zhang Y-F, Wang Y-M, et al. Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma. Acta Obstet Gynecol Scand 2015;94:266-73. · DOI
  79. Bhosale P, Ma J, Iyer R, et al. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging 2016;43:316-24. · DOI
  80. Lin G, Huang Y-T, Chao A, et al. Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T. Eur Radiol 2017;27:1867-76. · DOI
  81. Alcazar JL, Pineda L, Martinez-Astorquiza Corral T, et al. Transvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approaches. J Gynecol Oncol 2015;26:201-7. · DOI
  82. Eriksson LSE, Lindqvist PG, Flöter Rådestad A, et al. Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists. Ultrasound Obstet Gynecol 2015;45:476-82. · DOI
  83. Vieillefosse S, Huchon C, Chammings F, et al. Assessment of different pre and intra-operative strategies to predict the actual ESMO risk group and to establish the appropriate indication of lymphadenectomy in endometrial cancer. J Gynecol Obstet Hum Reprod 2018;47:517-23. · DOI
  84. Jantarasaengaram S, Praditphol N, Tansathit T, et al. Three- dimensional ultrasound with volume contrast imaging for preoperative assessment of myometrial invasion and cervical involvement in women with endometrial cancer. Ultrasound Obstet Gynecol 2014;43:569-74. · DOI
  85. Pineda L, Alcázar JL, Caparrós M, et al. Agreement between preoperative transvaginal ultrasound and intraoperative macroscopic examination for assessing myometrial infiltration in low-risk endometrioid carcinoma. Ultrasound Obstet Gynecol 2016;47:369-73. · DOI
  86. Frühauf F, Zikan M, Semeradova I, et al. The diagnostic accuracy of ultrasound in assessment of myometrial invasion in endometrial copyright. on December 18, 2020 at KU Leuven Libraries. Protected by http://ijgc.bmj.com/ Int J Gynecol Cancer: first published as 10.1136/ijgc-2020-002230 on 18 December 2020. Downloaded from Joint statement cancer: subjective assessment versus objective techniques. Biomed Res Int 2017;2017:1-10. · DOI
  87. Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, et al. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med 2016;57:879-85. · DOI
  88. Legros M, Margueritte F, Tardieu A, et al. Para-aortic lymph node invasion in high-risk endometrial cancer: performance of (18)FDG PET-CT. Anticancer Res 2019;39:619-25. · DOI
  89. Kim HJ, Cho A, Yun M, et al. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med 2016;30:104-13. · DOI
  90. Chung HH, Cheon GJ, Kim HS, et al. Preoperative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer. Eur J Nucl Med Mol Imaging 2014;41:1793-9. · DOI
  91. Atakul BK, Taşkın S, Soydal Ç, et al. Preoperative 18F- fluorodeoxyglucose positron emission tomography/CT in prediction of uterine risk factors and lymph node metastasis: an analysis of 111 endometrioid endometrial cancer patients. Gynecol Obstet Invest 2017;82:340-8. · DOI
  92. Kulkarni R, Bhat RA, Dhakharia V, et al. Role of positron emission tomography/computed tomography in preoperative assessment of carcinoma endometrium-a retrospective analysis. Indian J Surg Oncol 2019;10:225-31. · DOI
  93. Tanaka T, Terai Y, Yamamoto K, et al. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer. Medicine 2018;97:e12522. · DOI
  94. Bese T, Sal V, Demirkiran F, et al. The combination of preoperative fluorodeoxyglucose positron emission tomography/computed tomography and sentinel lymph node mapping in the surgical management of endometrioid endometrial cancer. Int J Gynecol Cancer 2016;26:1228-38. · DOI
  95. Park J-Y, Lee JJ, Choi HJ, et al. The value of preoperative positron emission tomography/computed tomography in node-negative endometrial cancer on magnetic resonance imaging. Ann Surg Oncol 2017;24:2303-10. · DOI
  96. Gülseren V, Kocaer M, Çelikkol Güngördük Ö, et al. Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre-and postmenopausal periods in endometrioid-type endometrial cancer? Turk J Obstet Gynecol 2018;15:60-4. · DOI
  97. Gholkar NS, Saha SC, Prasad G, et al. The accuracy of integrated [(18)F] fluorodeoxyglucose-positron emission tomography/ computed tomography in detection of pelvic and para-aortic nodal metastasis in patients with high risk endometrial cancer. World J Nucl Med 2014;13:170-7. 100 · DOI
  98. Mayoral M, Paredes P, Domènech B, et al. 18 F-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging. Rev Esp Med Nucl Imagen Mol 2017;36:20-6. 101 · DOI
  99. Ghooshkhanei H, Treglia G, Sabouri G, et al. Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: a systematic review and meta- analysis. Gynecol Oncol 2014;132:669-76. 102 · DOI
  100. Dai S, Nahas S, Murphy JK, et al. Impact and cost of preoperative computed tomography imaging on the management of patients diagnosed with high-grade endometrial cancer. Int J Gynecol Obstet 2019;145:219-24. 103 · DOI
  101. Bogani G, Gostout BS, Dowdy SC, et al. Clinical utility of preoperative computed tomography in patients with endometrial cancer. Int J Gynecol Cancer 2017;27:1685-93. 104 · DOI
  102. Janda M, Gebski V, Davies LC, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer. JAMA 2017;317:1224-33. 105 · DOI
  103. Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study. JCO 2012;30:695-700. 106 · DOI
  104. Togami S, Kawamura T, Fukuda M, et al. Learning curve and surgical outcomes for laparoscopic surgery, including pelvic lymphadenectomy, for early stage endometrial cancer. Jpn J Clin Oncol 2019;49:521-4. 107 · DOI
  105. Deura I, Shimada M, Azuma Y, et al. Comparison of laparoscopic surgery and conventional laparotomy for surgical staging of patients with presumed low-risk endometrial cancer: the current state of Japan. Taiwan J Obstet Gynecol 2019;58:99-104. 108 · DOI
  106. Ghazali WHW, Jamil S, Sharin I. Laparoscopic versus laparotomy: Staging surgery for endometrial cancer -Malaysia's early experience. Gynecol Minim Invasive Ther 2019;8:25-9. 109 · DOI
  107. Vardar MA, Gulec UK, Guzel AB, et al. Laparoscopic surgery for low, intermediate and high-risk endometrial cancer. J Gynecol Oncol 2019;30:e24. 110 · DOI
  108. Pookunju AP, Ayyappan S. Technique of laparoscopic hysterectomy and pelvic lymphadenectomy for endometrial cancer. Indian J Surg Oncol 2018;9:290-3. 111 · DOI
  109. Wollinga T, Ezendam NPM, Eggink FA, et al. Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade. Gynecol Surg 2018;15:7. 112 · DOI
  110. Van den Bosch A, Mertens H. Implementation of laparoscopic surgery for endometrial cancer: work in progress. Facts Views Vis Obgyn 2016;8:23-30. 113
  111. Chu L-H, Chang W-C, Sheu B-C. Comparison of the laparoscopic versus conventional open method for surgical staging of endometrial carcinoma. Taiwan J Obstet Gynecol 2016;55:188-92. 114 · DOI
  112. Favero G, Anton C, Le X, et al. Oncologic safety of laparoscopy in the surgical treatment of type II endometrial cancer. Int J Gynecol Cancer 2016;26:1673-8. 115 · DOI
  113. Bennich G, Rudnicki M, Lassen PD. Laparoscopic surgery for early endometrial cancer. Acta Obstet Gynecol Scand 2016;95:894-900. 116 · DOI
  114. Lee C-L, Kusunoki S, Huang K-G, et al. Long-term survival outcomes of laparoscopic staging surgery in treating endometrial cancer: 20 years of follow-up. Taiwan J Obstet Gynecol 2016;55:545-51. 117 · DOI
  115. Berretta R, Gizzo S, Noventa M, et al. Quality of life in patients affected by endometrial cancer: comparison among laparotomy, laparoscopy and vaginal approach. Pathol Oncol Res 2015;21:811-6. 118 · DOI
  116. Yin X, Shi M, Xu J, et al. Perioperative and long-term outcomes of laparoscopy and laparotomy for endometrial carcinoma. Int J Clin Exp Med 2015;8:19093-9. 119
  117. Kroft J, Li Q, Saskin R, et al. Trends over time in the use of laparoscopic hysterectomy for the treatment of endometrial cancer. Gynecol Oncol 2015;138:536-41. 120 · DOI
  118. Pawłowicz PS, Ajdacka U. The role of laparoscopy in the surgical treatment of endometrial cancer. Wiitm 2015;1:44-8. 121 · DOI
  119. Gao H, Zhang Z. Laparoscopy versus laparotomy in the treatment of high-risk endometrial cancer: a propensity score matching analysis. Medicine 2015;94:e1245. 122
  120. Şenol T, Polat M, Şanverdi I, et al. Laparoscopic staging of endometrial cancer: does it have any impact on survival? Turk J Obstet Gynecol 2015;12:139-43. 123 · DOI
  121. Palomba S, Ghezzi F, Falbo A, et al. Conversion in endometrial cancer patients scheduled for laparoscopic staging: a large multicenter analysis: conversions and endometrial cancer. Surg Endosc 2014;28:3200-9. 124 · DOI
  122. Lee C-L, Huang K-G, Wu P-J, et al. Long-term survival outcome of laparoscopic staging surgery for endometrial cancer in Taiwanese experience. Taiwan J Obstet Gynecol 2014;53:57-61. 125 · DOI
  123. Terai Y, Tanaka T, Sasaki H, et al. Total laparoscopic modified radical hysterectomy with lymphadenectomy for endometrial cancer compared with laparotomy. J Obstet Gynaecol Res 2014;40:570-5. 126 · DOI
  124. Koskas M, Jozwiak M, Fournier M, et al. Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer. Eur J Cancer 2016;65:185-91. 127 · DOI
  125. Uccella S, Bonzini M, Palomba S, et al. Laparoscopic vs. open treatment of endometrial cancer in the elderly and very elderly: an age-stratified multicenter study on 1606 women. Gynecol Oncol 2016;141:211-7. 128 · DOI
  126. Bogani G, Cromi A, Uccella S, et al. Perioperative and long-term outcomes of laparoscopic, open abdominal, and vaginal surgery for endometrial cancer in patients aged 80 years or older. Int J Gynecol Cancer 2014;24:894-900. 129 · DOI
  127. Baek M-H, Lee S-W, Park J-Y, et al. Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: long-term results at a single institution. J Korean Med Sci 2014;29:1536-43. 130 · DOI
  128. Bogani G, Cromi A, Uccella S, et al. Laparoscopic staging in women older than 75 years with early-stage endometrial cancer: comparison with open surgical operation. Menopause 2014;21:945-51. 131 · DOI
  129. Freeman AH, Barrie A, Lyon L, et al. Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol 2016;142:267-72. copyright. on December 18, 2020 at KU Leuven Libraries. Protected by http://ijgc.bmj.com/ Int J Gynecol Cancer: first published as 10.1136/ijgc-2020-002230 on 18 December 2020. Downloaded from Joint statement 132 · DOI
  130. Raventós-Tato RM, de la Torre-Fernández de Vega J, Sánchez- Iglesias JL, et al. Surgical approaches in women with endometrial cancer with a body mass index greater than 35 kg/m 2 . J Obstet Gynaecol Res 2019;45:195-202. 133 · DOI
  131. Bishop EA, Java JJ, Moore KN, et al. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol 2018;218:109.e1-109.e11. 134 · DOI
  132. Casarin J, Multinu F, Ubl DS, et al. Adoption of minimally invasive surgery and decrease in surgical morbidity for endometrial cancer treatment in the United States. Obstet Gynecol 2018;131:304-11. 135 · DOI
  133. Ee WW, Nellore V, McMullen W, et al. Laparoscopic hysterectomy for endometrial cancer: impact of age on clinical outcomes. J Obstet Gynaecol 2018;38:734. 136 · DOI
  134. Singh S, Swarer K, Resnick K. Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer. Gynecol Oncol 2017;147:554-7. 137 · DOI
  135. Bregar AJ, Melamed A, Diver E, et al. Minimally invasive staging surgery in women with early-stage endometrial cancer: analysis of the National Cancer Data Base. Ann Surg Oncol 2017;24:1677-87. 138 · DOI
  136. Monterossi G, Ghezzi F, Vizza E, et al. Minimally invasive approach in type II endometrial cancer: is it wise and safe? J Minim Invasive Gynecol 2017;24:438-45. 139 · DOI
  137. Barber EL, Gehrig PA, Clarke-Pearson DL. Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer. Obstet Gynecol 2016;128:121-6. 140 · DOI
  138. Pulman KJ, Dason ES, Philp L, et al. Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Obstet 2017;136:315-9. 141 · DOI
  139. Marcos-Sanmartín J, López Fernández JA, Sánchez-Payá J, et al. Does the type of surgical approach and the use of uterine manipulators influence the disease-free survival and recurrence rates in early-stage endometrial cancer? Int J Gynecol Cancer 2016;26:1722-6. 142 · DOI
  140. Tanaka T, Terai Y, Hayashi S, et al. Comparison between laparoscopy and laparotomy in systematic para-aortic lymphadenectomy for patients with endometrial cancer: a retrospective multicenter study. J Gynecol Surg 2017;33:105-10. 143 · DOI
  141. Galaal K, Donkers H, Bryant A, et al. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev 2018;10. 144 · DOI
  142. Asher R, Obermair A, Janda M, et al. Disease-free and survival outcomes for total laparoscopic hysterectomy compared with total abdominal hysterectomy in early-stage endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 2018;28:529-38. 145 · DOI
  143. Mahajan V. Prospective nonrandomized comparative study of laparoscopic versus open surgical staging for endometrial cancer in India. Indian J Surg Oncol 2018;9:133-40. 146 · DOI
  144. Jørgensen SL, Mogensen O, Wu C, et al. Nationwide introduction of minimally invasive robotic surgery for early-stage endometrial cancer and its association with severe complications. JAMA Surg 2019;154:530. 147 · DOI
  145. Kyrgiou M, Swart AM, Qian W, et al. A comparison of outcomes following laparoscopic and open hysterectomy with or without lymphadenectomy for presumed early-stage endometrial cancer: results from the Medical Research Council ASTEC trial. Int J Gynecol Cancer 2015;25:1424-36. 148
  146. Park DA, Lee DH, Kim SW, et al. Comparative safety and effectiveness of robot-assisted laparoscopic hysterectomy versus conventional laparoscopy and laparotomy for endometrial cancer: a systematic review and meta-analysis. Eur J Surg Oncol 2016;42:1303-14. 149 · DOI
  147. Ran L, Jin J, Xu Y, et al. Comparison of robotic surgery with laparoscopy and laparotomy for treatment of endometrial cancer: a meta-analysis. PLoS One 2014;9:e108361. 150 · DOI
  148. Nevis IF, Vali B, Higgins C, et al. Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review. J Robot Surg 2017;11:1-16. 151 · DOI
  149. Lundin ES, Wodlin NB, Nilsson L, et al. A prospective randomized assessment of quality of life between open and robotic hysterectomy in early endometrial cancer. Int J Gynecol Cancer 2019. doi:10.1136/ ijgc-2019-000285. [Epub ahead of print: 28 Mar 2019]. 152 · DOI
  150. Uccella S, Bonzini M, Palomba S, et al. Impact of obesity on surgical treatment for endometrial cancer: a multicenter study comparing laparoscopy vs open surgery, with propensity-matched analysis. J Minim Invasive Gynecol 2016;23:53-61. 154 · DOI
  151. Corrado G, Mereu L, Bogliolo S, et al. Robotic single site staging in endometrial cancer: a multi-institution study. Eur J Surg Oncol 2016;42:1506-11. 155 · DOI
  152. Backes FJ, El Naggar AC, Farrell MR, et al. Perioperative outcomes for laparotomy compared to robotic surgical staging of endometrial cancer in the elderly: a retrospective cohort. Int J Gynecol Cancer 2016;26:1717-21. 156 · DOI
  153. Guy MS, Sheeder J, Behbakht K, et al. Comparative outcomes in older and younger women undergoing laparotomy or robotic surgical staging for endometrial cancer. Am J Obstet Gynecol 2016;214:350.e1-350.e10. 157 · DOI
  154. Herling SF, Havemann MC, Palle C, et al. Robotic-Assisted laparoscopic hysterectomy seems safe in women with early-stage endometrial cancer. Dan Med J 2015;62:A5109. 158
  155. Beck TL, Schiff MA, Goff BA, et al. Robotic, laparoscopic, or open hysterectomy: surgical outcomes by approach in endometrial cancer. J Minim Invasive Gynecol 2018;25:986-93. 159 · DOI
  156. Doo DW, Guntupalli SR, Corr BR, et al. Comparative surgical outcomes for endometrial cancer patients 65 years old or older staged with robotics or laparotomy. Ann Surg Oncol 2015;22:3687-94. 160 · DOI
  157. Park HK, Helenowski IB, Berry E, et al. A comparison of survival and recurrence outcomes in patients with endometrial cancer undergoing robotic versus open surgery. J Minim Invasive Gynecol 2015;22:961-7. 161 · DOI
  158. Feuer GA, Lakhi N, Woo A, et al. Robotic surgery for staging of serous papillary and clear cell carcinoma of the endometrium. Int J Med Robotics Comput Assist Surg 2014;10:306-13. 162 · DOI
  159. Pant A, Schink J, Lurain J. Robotic surgery compared with laparotomy for high-grade endometrial cancer. J Robot Surg 2014;8:163-7. 163 · DOI
  160. Safdieh J, Lee Y-C, Wong A, et al. A comparison of outcomes between open hysterectomy and robotic-assisted hysterectomy for endometrial cancer using the National Cancer Database. Int J Gynecol Cancer 2017;27:1508-16. 164 · DOI
  161. Wright JD, Burke WM, Tergas AI, et al. Comparative effectiveness of minimally invasive hysterectomy for endometrial cancer. JCO 2016;34:1087-96. 165 · DOI
  162. Barraez D, Godoy H, McElrath T, et al. Low incidence of port-site metastasis after robotic assisted surgery for endometrial cancer staging: descriptive analysis. J Robot Surg 2015;9:91-5. 166 · DOI
  163. Yoon A, Yoo H-N, Lee Y-Y, et al. Robotic single-port hysterectomy, adnexectomy, and lymphadenectomy in endometrial cancer. J Minim Invasive Gynecol 2015;22:322. 167 · DOI
  164. Geppert B, Persson J. Robotic infrarenal paraaortic and pelvic nodal staging for endometrial cancer: feasibility and lymphatic complications. Acta Obstet Gynecol Scand 2015;94:1074-81. 168 · DOI
  165. Damiani GR, Turoli D, Cormio G, et al. Robotic approach using simple and radical hysterectomy for endometrial cancer with long- term follow-up evaluation. Int J Med Robotics Comput Assist Surg 2016;12:109-13. 169 · DOI
  166. Bige O, Demir A, Saatli B, et al. Laparoscopy versus laparotomy for the management of endometrial carcinoma in morbidly obese patients: a prospective study. J Turkish German Gynecol Assoc 2015;16:164-9. 170 · DOI
  167. Salehi S, Åvall-Lundqvist E, Legerstam B, et al. Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: a randomised controlled trial. Eur J Cancer 2017;79:81-9. 171 · DOI
  168. Salehi S, Brandberg Y, Åvall-Lundqvist E, et al. Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer -results from the RASHEC trial. Acta Oncol 2018;57:1671-6. 172 · DOI
  169. Signorelli M, Lissoni AA, Cormio G, et al. Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study. Ann Surg Oncol 2009;16:3431-41. 173 · DOI
  170. Kaban A, Topuz S, Erdem B, et al. Is omentectomy necessary for non-endometrioid endometrial cancer. Gynecol Obstet Invest 2018;83:482-6. 174 · DOI
  171. Joo WD, Schwartz PE, Rutherford TJ, et al. Microscopic omental metastasis in clinical stage I endometrial cancer: a meta-analysis. Ann Surg Oncol 2015;22:3695-700. 175 · DOI
  172. Ross MS, Elishaev E, Berger JL, et al. Prognostic significance of omental disease and the role of omental sampling in patients with uterine carcinosarcoma. Int J Gynecol Cancer 2018;28:254-9. 176 · DOI
  173. Lee B, Suh DH, Kim K, et al. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis. Jpn J Clin Oncol 2016;46:711-7. copyright. on December 18, 2020 at KU Leuven Libraries. Protected by http://ijgc.bmj.com/ Int J Gynecol Cancer: first published as 10.1136/ijgc-2020-002230 on 18 December 2020. Downloaded from Joint statement 177 · DOI
  174. Matsuo K, Yabuno A, Hom MS, et al. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer. Gynecol Oncol 2018;149:301-9. 178 · DOI
  175. Seagle B-LL, Alexander AL, Lantsman T, et al. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database. Am J Obstet Gynecol 2018;218:329.e1-329.e15. 179 · DOI
  176. Bogani G, Murgia F, Ditto A, et al. Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 2019;153:676-83. 180 · DOI
  177. Leitao MM. Sentinel lymph node mapping in patients with endometrial carcinoma: less can be more. Curr Obstet Gynecol Rep 2016;5:279-85. 181 · DOI
  178. Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017;18:384-92. 182 · DOI
  179. Persson J, Salehi S, Bollino M, et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019;116:77-85. 183 · DOI
  180. Daraï E, Dubernard G, Bats A-S, et al. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol 2015;136:54-9. 184 · DOI
  181. Renz M, Marjon N, Devereaux K, et al. Immediate intraoperative sentinel lymph node analysis by frozen section is predictive of lymph node metastasis in endometrial cancer. J Robot Surg 2020;14:35-40. 185 · DOI
  182. How JA, O'Farrell P, Amajoud Z, et al. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta- analysis. Minerva Ginecol 2018;70:194-214. 186 · DOI
  183. Lin H, Ding Z, Kota VG, et al. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget 2017;8:46601-10. 187 · DOI
  184. Staley A, Sullivan SA, Rossi EC. Sentinel lymph node technique in endometrial cancer. Obstet Gynecol Surv 2017;72:289-95. 188 · DOI
  185. Tschernichovsky R, Diver EJ, Schorge JO, et al. The role of lymphadenectomy versus sentinel lymph node biopsy in early- stage endometrial cancer. Am J Clin Oncol 2016;39:516-21. 189 · DOI
  186. Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta- analysis. Am J Obstet Gynecol 2017;216:459-76. 190 · DOI
  187. Wang L, Liu F. Meta-analysis of laparoscopy sentinel lymph node mapping in endometrial cancer. Arch Gynecol Obstet 2018;298:505-10. 191 · DOI
  188. Baiocchi G, Mantoan H, Kumagai LY, et al. The impact of sentinel node-mapping in staging high-risk endometrial cancer. Ann Surg Oncol 2017;24:3981-7. 192 · DOI
  189. Tanner E, Puechl A, Levinson K, et al. Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. Gynecol Oncol 2017;147:535-40. 193 · DOI
  190. Martinelli F, Ditto A, Signorelli M, et al. Sentinel node mapping in endometrial cancer following hysteroscopic injection of tracers: a single center evaluation over 200 cases. Gynecol Oncol 2017;146:525-30. 194 · DOI
  191. Buda A, Di Martino G, Restaino S, et al. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: an Italian retrospective analysis of two reference centers. Gynecol Oncol 2017;147:528-34. 195 · DOI
  192. Yamagami W, Susumu N, Kataoka F, et al. A comparison of dye versus fluorescence methods for sentinel lymph node mapping in endometrial cancer. Int J Gynecol Cancer 2017;27:1517-24. 196 · DOI
  193. Touhami O, Grégoire J, Renaud M-C, et al. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. Gynecol Oncol 2017;147:549-53. 197 · DOI
  194. Papadia A, Buda A, Gasparri ML, et al. The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer. J Cancer Res Clin Oncol 2018;144:2187-91. 198 · DOI
  195. Eoh KJ, Lee YJ, Kim H-S, et al. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: a novel sentinel lymph node tracer injection procedure. Surg Oncol 2018;27:514-9. 199 · DOI
  196. Ducie JA, Eriksson AGZ, Ali N, et al. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease. Gynecol Oncol 2017;147:541-8. 200 · DOI
  197. Tanner EJ, Ojalvo L, Stone RL, et al. The utility of sentinel lymph node mapping in high-grade endometrial cancer. Int J Gynecol Cancer 2017;27:1416-21. 201 · DOI
  198. How J, Gauthier C, Abitbol J, et al. Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer. Gynecol Oncol 2017;144:503-9. 202 · DOI
  199. Papadia A, Zapardiel I, Bussi B, et al. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol 2017;143:475-80. 203 · DOI
  200. Tanaka T, Terai Y, Fujiwara S, et al. The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer. Int J Clin Oncol 2018;23:305-13. 204 · DOI

200 of 426 shown

Cited by

Sorted by citations

Authors
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., Fotopoulou, C., Gonzalez Martin, A., Lax, S., Lorusso, D., Marth, C., Morice, P., Nout, R. A., O'Donnell, D., Querleu, D., Raspollini, M. R., Sehouli, J., Sturdza, A., Taylor, A., Westermann, A., Wimberger, P., Colombo, N., Planchamp, F., & Creutzberg, C. L.
Affiliations
  • Innsbruck Medical University (AT)
  • KU Leuven (BE)
  • Charles University (CZ)
  • Copenhagen University Hospital (DK)
  • University of Cologne (DE)
  • University College London (GB)
  • Leiden University Medical Center (NL)
  • Institut Gustave Roussy (FR)
  • Agostino Gemelli University Polyclinic (IT)
  • Imperial College London (GB)
  • Johannes Kepler University of Linz (AT)
  • Erasmus MC Cancer Institute (NL)
  • Azienda Ospedaliero-Universitaria Careggi (IT)
  • Humboldt-Universität zu Berlin (DE)
  • Comprehensive Cancer Center Vienna (AT)
  • Royal Marsden Hospital (GB)
  • Amsterdam University Medical Centers (NL)
  • University Hospital Carl Gustav Carus (DE)
  • University of Milan (IT)
  • Institut Bergonié (FR)
ORCID
Venue
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Published
2021-01
Volume
31
Issue
1
Pages
12-39
ISSN
1048-891X (ISSN-L)
DOI
10.1136/ijgc-2020-002230
OpenAlex
W3114074286
Cited by
1,989
References
1
Citations by year
2026: 267 · 2025: 399 · 2024: 417 · 2023: 428 · 2022: 322 · 2021: 153 · 2020: 1 · 2012: 1
FWCI
139.49
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Gynecological Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • UCL Discovery (University College London) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by-nc)
  • Lirias (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
  • UCL Discovery (University College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Repositori ObertUDL (University of Lleida) (submittedVersion, other-oa)
Funders
  • Amgen
  • Pfizer
  • AstraZeneca
  • Karyopharm Therapeutics
  • Regeneron Pharmaceuticals
  • Novocure
  • Clovis Oncology
  • Deciphera Pharmaceuticals
  • Carrick Therapeutics
  • Verastem Oncology
  • Austrian Science Fund
  • Eisai
  • KU Leuven
  • European Society for Medical Oncology
  • PharmaMar
  • MSD Italia
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
Keywords
endometrial cancer, clinical management, multidisciplinary care, evidence-based recommendations, quality of care, gynecologic oncology, radiotherapy, pathology
MeSH terms
Europe, Female, Genital Neoplasms, Female, Humans, Medical Oncology, Preoperative Care, Risk Factors, Endometrial Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review